0000950170-24-012453.txt : 20240207 0000950170-24-012453.hdr.sgml : 20240207 20240207202337 ACCESSION NUMBER: 0000950170-24-012453 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240205 FILED AS OF DATE: 20240207 DATE AS OF CHANGE: 20240207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ossip David D CENTRAL INDEX KEY: 0001733805 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38467 FILM NUMBER: 24606505 MAIL ADDRESS: STREET 1: C/O CERIDIAN HCM HOLDING INC. STREET 2: 3311 EAST OLD SHAKOPEE ROAD CITY: MINNEAPOLIS STATE: MN ZIP: 55425 FORMER NAME: FORMER CONFORMED NAME: Ossip David O DATE OF NAME CHANGE: 20180307 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dayforce, Inc. CENTRAL INDEX KEY: 0001725057 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] ORGANIZATION NAME: 06 Technology IRS NUMBER: 463231686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3311 EAST OLD SHAKOPEE ROAD CITY: MINNEAPOLIS STATE: MN ZIP: 55425 BUSINESS PHONE: 952-853-8100 MAIL ADDRESS: STREET 1: 3311 EAST OLD SHAKOPEE ROAD CITY: MINNEAPOLIS STATE: MN ZIP: 55425 FORMER COMPANY: FORMER CONFORMED NAME: Ceridian HCM Holding Inc. DATE OF NAME CHANGE: 20171212 4 1 ownership.xml 4 X0508 4 2024-02-05 0001725057 Dayforce, Inc. DAY 0001733805 Ossip David D C/O DAYFORCE, INC. 3311 EAST OLD SHAKOPEE ROAD MINNEAPOLIS MN 55425 true true false false Chairman and CEO false Common Stock 691963 D Common Stock 229085 I See Note Performance Units 2024-02-05 4 M false 0 0 D 2033-02-28 Common Stock 5088 5088 D Performance Units 2024-02-05 4 M false 0 0 D 2033-02-28 Common Stock 64276 64276 D Exchangeable Shares Common Stock 8328 8328 D Exchangeable Shares Common Stock 1860902 1860902 I See Note Option (right to buy) 22.00 2028-04-25 Common Stock 858697 858697 D Option (right to buy) 44.91 2029-02-08 Common Stock 10390 10390 D Option (right to buy) 49.93 2029-03-20 Common Stock 1750000 1750000 D Option (right to buy) 65.26 2030-05-08 Common Stock 1500000 1500000 D Option (right to buy) 65.26 2030-05-08 Common Stock 321734 321734 D Option (right to buy) 80.95 2031-03-08 Common Stock 226931 226931 D Performance Units 2031-03-08 Common Stock 4942 4942 D Performance Units 2031-03-08 Common Stock 27794 27794 D Performance Units 2032-02-24 Common Stock 4705 4705 D Performance Units 2032-02-24 Common Stock 52922 52922 D Performance Units 2033-02-28 Common Stock 27423 27423 D Includes 22,267 shares of common stock of the Company ("Common Stock"), and, subject to forfeiture should the recipient fails to make an election to convert to shares prior to the ten year anniversary of the grant date, (i) 500,000 restricted stock units ("RSUs") granted on March 20, 2017, that are issuable as shares of Common Stock at the election of the recipient; (ii) 3,129 RSUs granted on February 28, 2020, that are issuable as shares of Common Stock at the election of the recipient, (iii) 34,477 RSUs granted on May 8, 2020, that are issuable as shares of Common Stock at the election of the recipient, (iv) of the 63,532 RSUs granted on February 24, 2022, 21,177 shares of Common Stock are issuable at the election of the recipient, 21,177 RSUs vest and become issuable at the election of the recipient on February 24, 2024, and 21,178 RSUs vest and become issuable at the election of the recipient on February 24, 2025. Includes, subject to forfeiture should the recipient fail to make an election to convert to shares prior to the ten year anniversary of the grant date, (i) shares of Common Stock issuable pursuant to RSUs, granted on February 28, 2023, of which 22,852 RSUs vest and become issuable at the election of the recipient on February 28, 2024, and 22,853 RSUs vest and become issuable at the election of the recipient on each of February 28, 2025, and February 28, 2026. Indirectly owned through OsFund Inc. The Reporting Person disclaims beneficial ownership except to the extent of the Reporting Person's pecuniary interest. On February 28, 2023, the Reporting Person was granted performance stock units ("PSUs") subject to the Company's 2023 Management Incentive Plan, the vesting of which was subject to both performance-based and service-based criteria. The number of shares reported represents the number of PSUs that were earned as a result of the achievement of such performance criteria. Such earned PSUs will vest as to service on February 28, 2024, subject to the Reporting Person remaining in continuous Service (as defined in the Company's 2018 Equity Incentive Plan) of the Company as of such date. The Reporting Person has until February 28, 2033 to elect to convert any or all of the vested PSUs into shares of Common Stock. On February 28, 2023, the Reporting Person was granted PSUs subject to the terms of the PSU award agreement, the vesting of which was subject to both performance-based and service-based criteria. The number of shares reported represents the number of PSUs that were earned as a result of the achievement of such performance criteria. Such earned PSUs will vest as to service on February 28, 2024, subject to the Reporting Person remaining in continuous Service (as defined in the Company's 2018 Equity Incentive Plan) of the Company as of such date. In addition to the PSUs vesting on February 28, 2024, 22,853 PSUs will vest on each of February 28, 2025 and February 28, 2026, subject to the certification of the achievement of performance-based criteria by the Compensation Committee or the Board of Directors of the Company, and adjusted to reflect actual results during each of the preceding periods beginning on January 1 and ending December 31. The Reporting Person has until February 28, 2033 to elect to convert any or all of the vested PSUs into shares of Common Stock. Each PSU represents a contingent right to receive shares of Common Stock based upon the degree to which one or more of the performance metrics contained in the PSU award agreement are satisfied annually over a three year period. The number of PSUs reported in column 9 of Table II reflects achievement at the target level of performance under the PSU award agreement. Based on actual results during each of the preceding period beginning on January 1 and ending December 31, the aggregate number of shares of Common Stock issued may range from zero shares to 167% of the target number of shares reported in column 9 of Table II. The PSUs will only vest if the achievement of one or more of the annual performance metrics under the PSU award agreement is certified to have been met by the Compensation Committee or the Board of Directors of the Company for the prior period, and then any such certified amount will vest on the anniversary of the date of grant. Represents exchangeable shares of Ceridian AcquisitionCo ULC, a wholly owned subsidiary of the Issuer, that are exchangeable at the option of the holder for shares of common stock of the Issuer. Each exchangeable share is convertible into one share of common stock of the Issuer, subject to adjustment. The exchangeable shares are currently exercisable and have no expiration date. Indirectly owned through Osscer Inc. The Reporting Person disclaims beneficial ownership except to the extent of the Reporting Person's pecuniary interest. Fully vested and exercisable. The vesting conditions for this award are based on the Issuer's performance on the New York Stock Exchange ("NYSE") with (i) 750,000 shares available to vest when the Issuer's per share closing price on the NYSE meets or exceeds $110.94, or 1.7 times the exercise price, for ten consecutive trading days ("Performance Metric #1") and (ii) the remaining 750,000 shares are available to vest when the Issuer's per share closing price on the NYSE meets or exceeds $130.52, or 2.0 times the exercise price, for ten consecutive trading days ("Performance Metric #2", collectively with Performance Metric #1, the "Performance Metrics"). The vesting conditions of the Performance Metrics must be achieved prior to May 8, 2025, or any unvested portion of the award will terminate. Further, no portion of the award will vest and become exercisable until May 8, 2023, the third anniversary of the date of grant (the "Time-Based Metric"). The shares underlying Performance Metric #1, which was achieved on October 6, 2021, are vested and exercisable as of May 8, 2023. If Performance Metric #2 has not been achieved prior to May 8, 2025, the unvested portion of the award will terminate. Consists of 241,300 vested and exercisable options as of May 8, 2023, and 80,434 options that vest and become exercisable on May 8, 2024. Consists of 113,465 vested and exercisable options as of March 8, 2023, and 56,733 options that vest and become exercisable on each of March 8, 2024 and March 8, 2025. The vesting of 4,942 PSU occurred on March 8, 2022, and the recipient has until March 8, 2031 to elect to convert any or all of the vested PSUs into shares of Common Stock. The vesting of 9,264 PSUs occurred on March 8, 2022 and the vesting of 9,265 PSUs occurred on March 8, 2023, and the recipient has until March 8, 2031 to elect to convert any or all of the vested PSUs into shares of Common Stock. The vesting of 9,265 PSUs occurs on March 8, 2024. The vesting of 4,705 PSUs occurred on February 24, 2023, and the recipient has until February 24, 2032 to elect to convert any or all of the vested PSUs into shares of Common Stock. The vesting of 17,640 PSUs occurred on February 24, 2023, and the recipient has until February 24, 2032 to elect to convert any or all of the vested PSUs into shares of Common Stock. The vesting of 17,641 PSUs occurs on each of February 24, 2024, and February 24, 2025. Each PSU represents a contingent right to receive shares of Common Stock based upon the degree to which the performance metric contained in the PSU award agreement is satisfied. The number of PSUs reported in columns 7 and 9 of Table II reflects achievement at the target level of performance under the PSU award agreement. Based on actual results during the period beginning January 1, 2023, and ending December 31, 2025, the aggregate number of shares of Common Stock issued may range from zero shares to 200% of the target number of shares reported in columns 7 and 9 of Table II. The PSUs will only vest if the achievement of the performance metric under the PSU award agreement is certified to have been met by the Compensation Committee or the Board of Directors of the Company, and then any such certified amount will vest on February 28, 2026. Exhibit List 24. Power of Attorney /s/ William E. McDonald, attorney-in-fact 2024-02-07 EX-24.1 2 day-ex24_1.htm EX-24.1 EX-24.1

Exhibit 24.1

POWER OF ATTORNEY

 

March 7, 2023

 

Know all by these present, that the undersigned hereby constitutes and appoints William E. McDonald, Erik J. Didrikson, and Andrea R. Bastyr, or any one of them signing singly, and with full power of substitution, the undersigned's true and lawful attorney‑in‑fact to:

 

(1) execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Ceridian HCM Holding Inc. (the “Company”) or as a stockholder of the Company or as a trustee of a stockholder of the Company, (i) Forms 3, 4, and 5, and Schedules 13D or 13G, including amendments thereto, relating to the securities of the Company in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder, and (ii) Form 144 related to the sale of securities of the Company;

 

(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, Form 144, or Schedule 13D or 13G, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

 

(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney‑in‑fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney‑in‑fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney‑in‑fact may approve in such attorney‑in‑fact's discretion.

 

The undersigned hereby grants to each such attorney‑in‑fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney‑in‑fact, or such attorney‑in‑fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys‑in‑fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with, or liabilities that may arise under, Section 16 of the Securities Exchange Act of 1934.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5, file Form 144, or Schedules 13D or 13G with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys‑in‑fact.

 

This Power of Attorney shall not revoke any powers of attorney previously executed by the undersigned. This Power of Attorney shall not be revoked by any subsequent power of attorney that the undersigned may execute, unless such subsequent power of attorney specifically provides that it revokes this Power of Attorney by referring to the date of the undersigned’s execution of this Power of Attorney.

[The remainder of this page has been intentionally left blank]

 

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the day and year first above written.

 

 

 

/s/ David D. Ossip

Signature

 

David D. Ossip

Printed Name

 

[Signature Page to Power of Attorney]